John E. Jr. D. D. S. Maupin - 18 Apr 2022 Form 4 Insider Report for Encompass Health Corp (EHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Apr 2022, 14:02:21 UTC
Prior SEC filing
20 Jan 2022
Next SEC filing
17 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick Darby, attorney-in-fact for John E. Maupin, Jr., D.D.S.

Key filing fact

John E. Jr. D. D. S. Maupin filed Form 4 for Encompass Health Corp (EHC) on 20 Apr 2022.

Key facts

  • This page summarizes John E. Jr. D. D. S. Maupin's Form 4 filing for Encompass Health Corp (EHC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Apr 2022, 14:02.

Change

  • Previous filing in this sequence was filed on 20 Jan 2022.
  • Current net transaction value: +$578.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Award

Transaction value
$0
Shares
+298
Change %
+0.37%
Price
$0.000000
Shares after
81,254
Date
18 Apr 2022
Ownership
Direct
Footnotes
F1
EHC transaction

Encompass Health Common Stock

Award

Transaction value
$578
Shares
+8
Change %
+0.01%
Price
$72.28
Shares after
81,262
Date
19 Apr 2022
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Footnote F2

Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 18, 2022, the Company paid a dividend on common stock of $0.28 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .